abrdn Life Sciences Investors Overview
abrdn Life Sciences Investors Discounted Cash Flow
DCF Analysis for HQL.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.70
Current Fair Value
$-0.70
↓ 104.1% Downside
Overvalued by 104.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison